The pandemic of new coronavirus illness (COVID-19) is an unparalleled public health threat. According to studies, SARS-CoV-2 is transmitted mostly through contaminated droplets exhaled by sick patients, such as through coughing or sneezing. Individuals can be infected either directly or indirectly by fomites. Direct contact transmission occurs when infected people come into touch with saliva, respiratory secretions, or droplets that are expelled through coughing, sneezing, or speaking. Indirect contact transmission occurs when a susceptible host comes into contact with a contaminated object or surface (fomite transmission). The use of Nanoparticles in medicine has recently been hailed as ground-breaking, as it enables for accurate diagnosis and treatment of multiple diseases at once. Because of its small size, low toxicity, electrical charge, and chemical plasticity, a generic medicine can overcome a variety of barriers encountered during administration. SARS-CoV-2 entry and life cycle can be targeted with NP treatment. Several companies are continuously turning away from traditional SARS-CoV-2 treatment and preventive efforts in favor of employing nanotechnology to create and test various types of vaccines and therapies. Alternatives to this shift in the research and development paradigm could include nanotechnology and nanomedicine.
Important Alert:
X
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Making a nano bandaIdâ„¢: The merging of nanotechnology and artificial intelligence (AI) for improved medicin
Thomas J Webster, Hebei University of Technology, United States
Title : Current status of scaled-up synthesis/purification and characterization of a potentially translatabletantalum oxide nanoparticle intravenous CT contrast agent
Peter J Bonitatibus, RPI, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Artificial Intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix, Inc., United States
Title : Nanotechnology in nuclear reactors: Innovations in fusion and fission power generation
Bahman Zohuri, Galaxy Advanced Engineering, Mexico
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia